Grow Funds highlighted Paysign in its first-quarter 2026 investor letter, stating that the company’s fourth-quarter 2025 earnings beat expectations and proved AI and pharmaceutical disruption fears overblown. Paysign, a financial technology firm specializing in prepaid card programs and payment processing, reported revenue growth of 50.8% to $28 million in the first quarter of 2026. The fund noted that Paysign raised guidance for 2026 and remains inexpensive at 7 times enterprise value to EBITDA while growing revenues 40% last year. Grow Funds believes the company could begin returning capital to shareholders through dividends or share buybacks. Paysign shares gained 35.78% over the past 52 weeks and closed at $7.40 on June 18, 2026.
Paysign IncQ4 2025 earnings beat expectations, raised 2026 guidance, and shares gained 35.78% over 52 weeks.